Simon Farrell

Simon Farrell is listed in filings as Chief Commercial Officer at Trevi Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 20, 2026, including sale activity. Recent filings connect the profile to Trevi Therapeutics, Inc. (TRVI). The current snapshot covers public activity from Feb 20, 2025 to Feb 20, 2026. Reported amounts are shown as $951.6K to $56.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.